🕵️ Pliant Therapeutics, Inc. ($PLRX)
SEC insider & ownership activity, last 12 months · CIK 1746473 · every row links its SEC filing
Over the last 12 months insiders sold $164K with no open-market buying against it. Coulie Bernard sold $114K through a 10b5-1 trading plan in 1 lots (Jan). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 4 sellers, $164K (4 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Coulie Bernard | 0 | – | 1 | $114K | Jan 20, 2026 |
| Cummings Keith Lamont | 0 | – | 1 | $31K | Jan 20, 2026 |
| Cheung Lily | 0 | – | 1 | $10K | Jan 20, 2026 |
| Kuo Minnie | 0 | – | 1 | $9K | Jan 20, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Kevin Tang | 9.6% | 13D | Mar 3, 2025 | filing ↗ | |
| TANG Capital Management, LLC | 9.6% | 13D | Mar 3, 2025 | filing ↗ | |
| TANG Capital Partners, LP | 5.4% | 13D | Mar 3, 2025 | filing ↗ | |
| Kenneth Griffin | 5.0% | 13G | Feb 9, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 9, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 11, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 14, 2026 | filing ↗ |
| Other events (8.01) | Mar 27, 2026 | filing ↗ |
| Earnings (2.02) | Mar 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 11, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 3, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Mar 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 10, 2025 | filing ↗ |
| Officer/director changes (5.02) | Dec 2, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 20, 2025 | filing ↗ |
| Agreement terminated (1.02) | Oct 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |